keyword
https://read.qxmd.com/read/38464151/protective-effect-and-molecular-mechanisms-of-human-non-neutralizing-cross-reactive-spike-antibodies-elicited-by-sars-cov-2-mrna-vaccination
#21
Jordan Clark, Irene Hoxie, Daniel C Adelsberg, Iden A Sapse, Robert Andreata-Santos, Jeremy S Yong, Fatima Amanat, Johnstone Tcheou, Ariel Raskin, Gagandeep Singh, Irene González-Domínguez, Julia E Edgar, Stylianos Bournazos, Weina Sun, Juan Manuel Carreño, Viviana Simon, Ali H Ellebedy, Goran Bajic, Florian Krammer
Neutralizing antibodies correlate with protection against SARS-CoV-2. Recent studies, however, show that binding antibody titers, in the absence of robust neutralizing activity, also correlate with protection from disease progression. Non-neutralizing antibodies cannot directly protect from infection but may recruit effector cells thus contribute to the clearance of infected cells. Also, they often bind conserved epitopes across multiple variants. We characterized 42 human mAbs from COVID-19 vaccinated individuals...
March 1, 2024: bioRxiv
https://read.qxmd.com/read/38458875/virus-like-particles-of-louping-ill-virus-elicit-potent-neutralizing-antibodies-targeting-multimers-of-viral-envelope-protein
#22
JOURNAL ARTICLE
Rapeepat Tandavanitj, Chayanee Setthapramote, Giuditta De Lorenzo, Ricardo Sanchez-Velazquez, Jordan J Clark, Mara Rocchi, Colin McInnes, Alain Kohl, Arvind H Patel
Louping ill virus (LIV) is a tick-borne flavivirus that predominantly causes disease in livestock, especially sheep in the British Isles. A preventive vaccine, previously approved for veterinary use but now discontinued, was based on an inactivated whole virion that likely provided protection by induction of neutralizing antibodies recognizing the viral envelope (E) protein. A major disadvantage of the inactivated vaccine was the need for high containment facilities for the propagation of infectious virus, as mandated by the hazard group 3 status of the virus...
March 7, 2024: Vaccine
https://read.qxmd.com/read/38435157/assessment-of-knowledge-of-sexual-reproductive-health-among-female-university-students-in-jordan
#23
JOURNAL ARTICLE
Mais Alkhalili, Yamamah Al-Hmaid, Khalid Kheirallah, Lama Mehaisen
BACKGROUND: Sexual reproductive health (SRH) is an important aspect of human life, especially in the younger age groups. Young adults are the most vulnerable group to SRH consequences, as they have limited access to its information and services. This is one of the earliest studies conducted to examine the knowledge of SRH among female university students in Jordan. The aim of this study is to assess the knowledge of SRH among female Jordanian university students and to determine the social and individual factors that may affect this knowledge...
February 2024: Curēus
https://read.qxmd.com/read/38417340/respiratory-disease-complex-due-to-mixed-viral-infections-in-chicken-in-jordan
#24
JOURNAL ARTICLE
Mohammad Q Al-Natour, Mohammed A Rohaim, Rania F El Naggar, Mohammed A Abdelsabour, Ahmed F Afify, Yahia M Madbouly, Muhammad Munir
The global distribution of avian respiratory viruses highlights the need for effective surveillance programs and international collaboration to monitor viral circulation and implement timely control measures. In the current study, we aim to provide a comprehensive overview of avian respiratory viral infections in the poultry flocks in Jordan, focusing on the major viruses involved, their epidemiology, clinical manifestations, and evolution based on viroinformatics that will be helpful to improve the diagnostic methods, and control strategies including vaccines in the region...
February 16, 2024: Poultry Science
https://read.qxmd.com/read/38405899/immunization-of-cows-with-hiv-envelope-trimers-generates-broadly-neutralizing-antibodies-to-the-v2-apex-from-the-ultralong-cdrh3-repertoire
#25
Pilar X Altman, Gabriel Ozorowski, Robyn L Stanfield, Jeremy Haakenson, Michael Appel, Mara Parren, Wen-Hsin Lee, Huldah Sang, Jordan Woehl, Karen Saye-Francisco, Collin Joyce, Ge Song, Katelyn Porter, Elise Landais, Raiees Andrabi, Ian A Wilson, Andrew B Ward, Waithaka Mwangi, Vaughn V Smider, Dennis R Burton, Devin Sok
UNLABELLED: The generation of broadly neutralizing antibodies (bnAbs) to specific HIV epitopes of the HIV Envelope (Env) is one of the cornerstones of HIV vaccine research. The current animal models we use have been unable to reliable produce a broadly neutralizing antibody response, with the exception of cows. Cows have rapidly and reliably produced a CD4 binding site response by homologous prime and boosting with a native-like Env trimer. In small animal models other engineered immunogens previously have been able to focus antibody responses to the bnAb V2-apex region of Env...
February 14, 2024: bioRxiv
https://read.qxmd.com/read/38400117/exploring-vaccination-challenges-among-syrian-refugees-in-jordan-insights-from-camps-and-communities-and-perceived-parental-barriers-to-childhood-vaccination-uptake
#26
JOURNAL ARTICLE
Bayan Abdulhaq, Muhammad Hammouri, Dania Abu Hawas, Latefa Ali Dardas
PURPOSE: To identify and understand the multifaceted barriers faced by Syrian refugees when seeking vaccination services for their children. METHODS: A survey questionnaire was administered through structured interviews to a sample of Syrian refugees residing inside the Al-Zaatari camp and in various urban areas across Jordanian communities. This process utilized a multi-stage sampling approach, beginning with a random selection from clusters or strata, and then employing convenience sampling within each to select participants...
January 27, 2024: Vaccines
https://read.qxmd.com/read/38388238/clinical-formulation-development-of-plasmodium-falciparum-malaria-vaccine-candidates-based-on-pfs48-45-pfs230-and-pfcsp
#27
JOURNAL ARTICLE
Jordan Plieskatt, Peter Bang, Grith Krøyer Wood, Mohammad Naghizadeh, Susheel K Singh, Matthijs M Jore, Michael Theisen
Two malaria transmission-blocking vaccine (TBV) candidates, R0.6C and ProC6C, have completed preclinical development including the selection of adjuvants, Alhydrogel® with or without the saponin based adjuvant Matrix-M™. Here, we report on the final drug product (formulation) design of R0.6C and ProC6C and evaluate their safety and biochemical stability in preparation for preclinical and clinical pharmacy handling. The point-of-injection stability studies demonstrated that both the R0.6C and ProC6C antigens are stable on Alhydrogel in the presence or absence of Matrix-M for up to 24 h at room temperature...
February 21, 2024: Vaccine
https://read.qxmd.com/read/38380318/transgene-expression-knock-down-in-recombinant-modified-vaccinia-virus-ankara-vectors-improves-genetic-stability-and-sustained-transgene-maintenance-across-multiple-passages
#28
JOURNAL ARTICLE
Patrick Neckermann, Madlen Mohr, Martina Billmeier, Alexander Karlas, Ditte R Boilesen, Christian Thirion, Peter J Holst, Ingo Jordan, Volker Sandig, Benedikt Asbach, Ralf Wagner
Modified vaccinia virus Ankara is a versatile vaccine vector, well suited for transgene delivery, with an excellent safety profile. However, certain transgenes render recombinant MVA (rMVA) genetically unstable, leading to the accumulation of mutated rMVA with impaired transgene expression. This represents a major challenge for upscaling and manufacturing of rMVA vaccines. To prevent transgene-mediated negative selection, the continuous avian cell line AGE1.CR pIX (CR pIX) was modified to suppress transgene expression during rMVA generation and amplification...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38349280/interim-report-of-the-reactogenicity-and-immunogenicity-of-sars-cov-2-xbb-containing-vaccines
#29
JOURNAL ARTICLE
Spyros Chalkias, Nichole McGhee, Jordan L Whatley, Brandon Essink, Adam Brosz, Joanne E Tomassini, Bethany Girard, Darin K Edwards, Kai Wu, Arshan Nasir, Diana Lee, Laura E Avena, Jing Feng, Weiping Deng, David C Montefiori, Lindsey R Baden, Jacqueline M Miller, Rituparna Das
BACKGROUND: Monovalent Omicron XBB.1.5-containing vaccines were approved for Coronavirus disease 2019 (COVID-19) 2023-2024 immunizations. METHODS: This ongoing, open-label, phase 2/3 study evaluated mRNA-1273.815-monovalent (50-µg Omicron XBB.1.5-spike mRNA) and mRNA-1273.231-bivalent (25-µg each Omicron XBB.1.5- and BA.4/BA.5-spike mRNAs))vaccines, administered as 5th doses to adults who previously received a primary series, a 3rd dose of an original mRNA COVID-19 vaccine, and a 4th dose of an Omicron BA...
February 13, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38330357/recombinant-full-length-plasmodium-falciparum-circumsporozoite-protein-based-vaccine-adjuvanted-with-gla-lsq-results-of-phase-1-testing-with-malaria-challenge
#30
JOURNAL ARTICLE
DeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, Mallory Shriver, Catherine Cox, Jessica Butts, Jordan S Lundeen, Kathleen A Strauss, Sudhaunshu Joshi, Biraj Shrestha, Annie X Mo, Effie Y H Nomicos, Gregory A Deye, Jason A Regules, Elke S Bergmann-Leitner, Marcela F Pasetti, Matthew B Laurens
INTRODUCTION: Malaria is preventable yet causes >600,000 deaths annually. RTS, S, the first marketed malaria vaccine, has modest efficacy, but improvements are needed for eradication. METHODS: We conducted an open-label, dose escalation Phase 1 study of a recombinant, full-length circumsporozoite protein vaccine (rCSP) administered with adjuvant GLA-LSQ on days 1, 29, and 85 or 1 and 490 to healthy, malaria-naïve adults. Primary endpoints were safety and reactogenicity...
February 8, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38315362/production-and-purification-of-plasmodium-circumsporozoite-protein-in-lactococcus-lactis
#31
JOURNAL ARTICLE
Mohammad Naghizadeh, Susheel K Singh, Jordan Plieskatt, Ebenezer Addo Ofori, Michael Theisen
Malaria is a vector-borne disease caused by Plasmodium parasites of which Plasmodium falciparum contributed to an estimated 247 million cases worldwide in 2021 (WHO malaria report 2022). The P. falciparum Circumsporozoite protein (PfCSP) covers the surface of the sporozoite which is critical to cell invasion in the human host. PfCSP is the leading pre-erythrocytic vaccine candidate and forms the basis of the RTS'S (Mosquirix® ) malaria vaccine. However, high-yield production of full-length PfCSP with proper folding has been challenging...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38305633/il-15-complex-induced-il-10-enhances-plasmodium-specific-cd4-t-follicular-helper-differentiation-and-antibody-production
#32
JOURNAL ARTICLE
Morgan Bravo, Thamotharampillai Dileepan, Molly Dolan, Jacob Hildebrand, Jordan Wolford, Isabelle D Hanson, Sara E Hamilton, Anne E Frosch, Kristina S Burrack
Malaria, which results from infection with Plasmodium parasites, remains a major public health problem. Although humans do not develop long-lived, sterilizing immunity, protection against symptomatic disease develops after repeated exposure to Plasmodium parasites and correlates with the acquisition of humoral immunity. Despite the established role Abs play in protection from malaria disease, dysregulated inflammation is thought to contribute to the suboptimal immune response to Plasmodium infection. Plasmodium berghei ANKA (PbA) infection results in a fatal severe malaria disease in mice...
February 2, 2024: Journal of Immunology
https://read.qxmd.com/read/38299604/type-i-brugada-pattern-in-a-febrile-patient-following-covid-19-vaccination-booster
#33
JOURNAL ARTICLE
Robert Cacdac, Anthony Lim, Jonathan Ghazaleh, Shiva Salmasi, Sayna Poursadrolah, Monica Jordan, Andrew Rubin
There have been studies published regarding the association between developing Brugada syndrome after an acute COVID-19 infection. In this case, we present a patient who presented with a syncopal episode and subsequently found to have Type I Brugada pattern on electrocardiogram. The patient underwent placement of a single chamber defibrillator. Genetic analysis demonstrated SCN5A variant which is associated with cardiac conditions including Brugada syndrome.
2024: Journal of Investigative Medicine High Impact Case Reports
https://read.qxmd.com/read/38290009/a-randomized-first-in-human-phase-1-trial-of-differentially-adjuvanted-pfs48-45-malaria-vaccines-in-burkinab%C3%A3-adults
#34
JOURNAL ARTICLE
B Alfred Tiono, Jordan L Plieskatt, Alphonse Ouedraogo, Ben Idriss Soulama, Kazutoyo Miura, Edith C Bougouma, Mohammad Naghizadeh, Aissata Barry, Jean Baptiste B Yaro, Sem Ezinmegnon, Noelie B Henry, Ebenezer Ofori, Bright Adu, Susheel K Singh, Augustin Konkobo, Karin Lövgren Bengtsson, Amidou Diarra, Cecilia Carnrot, Jenny M Reimer, Amidou Z Ouedraogo, Moussa Tienta, Carole A Long, Issa N Nebie, Issaka Sagara, Sodiomon B Sirima, Michael Theisen
BACKGROUND: Malaria transmission blocking vaccines aim to interrupt the transmission of malaria from one person to another. METHODS: The candidates, R0.6C and ProC6C, share the Plasmodium falciparum sexual stage antigen, Pfs48/45 "6C" domain. R0.6C utilizes the Glutamate Rich Protein (GLURP) as a carrier and ProC6C includes a second domain (Pfs230-Pro) and a short 36 amino acids CSP sequence. Healthy adults (n = 125) from a malaria endemic area of Burkina Faso were immunized with three intramuscular injections, four weeks apart, of 30 μg or 100 μg R0...
January 30, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38288185/infection-control-in-hospitals-of-jordan-challenges-and-opportunities
#35
EDITORIAL
Mohammad Abu-Jeyyab, Batool Qura'an, Sallam Alrosan, Mohammad Al Mse'adeen
It is essential to take measures to prevent healthcare-associated infections (HAIs) and antibiotic resistance (AR) in order to ensure the safety of patients, control infections, protect public health, and maintain the overall quality and sustainability of the healthcare systems. The implementation of complex infection control strategies, the judicious utilization of antibiotics, health education, and global collaboration are necessary in order to address these significant challenges in the healthcare sector...
December 2023: Curēus
https://read.qxmd.com/read/38286593/-there-s-a-little-bit-of-mistrust-red-river-m%C3%A3-tis-experiences-of-the-h1n1-and-covid-19-pandemics
#36
JOURNAL ARTICLE
S Michelle Driedger, Ryan Maier, Gabriela Capurro, Cindy Jardine, Jordan Tustin, Frances Chartrand, Julianne Sanguins, Olena Kloss
We examined the perspectives of the Red River Métis citizens in Manitoba, Canada, during the H1N1 and COVID-19 pandemics and how they interpreted the communication of government/health authorities' risk management decisions. For Indigenous populations, pandemic response strategies play out within the context of ongoing colonial relationships with government institutions characterized by significant distrust. A crucial difference between the two pandemics was that the Métis in Manitoba were prioritized for early vaccine access during H1N1 but not for COVID-19...
January 29, 2024: Risk Analysis: An Official Publication of the Society for Risk Analysis
https://read.qxmd.com/read/38277361/prevalence-and-characteristics-of-long-covid-19-in-jordan-a-cross-sectional-survey
#37
JOURNAL ARTICLE
Marya Obeidat, Abdulmalek Abu Zahra, Farah Alsattari
Early in the pandemic, the spread of the emerging virus SARS-CoV-2 was causing mild illness lasting less than two weeks for most people, with a small proportion of people developing serious illness or death. However, as the pandemic progressed, many people reported suffering from symptoms for weeks or months after their initial infection. Persistence of COVID-19 symptoms beyond one month, or what is known as long COVID-19, is recognized as a risk of acute infection. Up to date, information on long COVID-19 among Jordanian patients has not been reported...
2024: PloS One
https://read.qxmd.com/read/38250828/evaluating-influenza-vaccination-practices-among-copd-patients
#38
JOURNAL ARTICLE
Walid Al-Qerem, Anan Jarab, Judith Eberhardt, Fawaz Alasmari, Saja K AbedAlqader
Chronic Obstructive Pulmonary Disease (COPD) stands as a global health concern linked to considerable morbidity and mortality. In Jordan, the prevalence of COPD is substantial, but research in this area is limited. Exacerbations of COPD can lead to severe outcomes, including hospitalization and increased cardiovascular risk. Influenza is a significant trigger of exacerbations in COPD patients, and vaccination is recommended. However, studies have shown negative attitudes towards the influenza vaccine. This cross-sectional study aimed to investigate the knowledge, attitudes, practices, and intentions of COPD patients in Jordan regarding influenza vaccination...
December 22, 2023: Vaccines
https://read.qxmd.com/read/38193825/association-between-covid-19-vaccines-and-development-of-chronic-morbidities-a-cross-sectional-study-in-the-jordanian-population
#39
JOURNAL ARTICLE
Mai I Al-Hawamdeh, Rana Abu-Huwaij, Thabit A Astiti, Ahmed K Al-Debe'e, Omar J Abazeed, Mohammed A Raees
BACKGROUND: In Jordan, individuals recently diagnosed with chronic illnesses have expressed concerns with regard to COVID-19 vaccines. This study aims to investigate potential associations between COVID-19 vaccination and the likelihood of recipients developing chronic conditions such as autoimmune diseases, rheumatoid arthritis, diabetes, asthma, and hypertension. METHODOLOGY: Through a cross-sectional survey-based descriptive approach, this research was conducted to gather data within the Jordanian context...
January 9, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/38184681/pvdbpii-elicits-multiple-antibody-mediated-mechanisms-that-reduce-growth-in-a-plasmodium-vivax-challenge-trial
#40
JOURNAL ARTICLE
Francisco J Martinez, Michael White, Micheline Guillotte-Blisnick, Christèle Huon, Alix Boucharlat, Fabrice Agou, Patrick England, Jean Popovici, Mimi M Hou, Sarah E Silk, Jordan R Barrett, Carolyn M Nielsen, Jenny M Reimer, Paushali Mukherjee, Virander S Chauhan, Angela M Minassian, Simon J Draper, Chetan E Chitnis
The receptor-binding domain, region II, of the Plasmodium vivax Duffy binding protein (PvDBPII) binds the Duffy antigen on the reticulocyte surface to mediate invasion. A heterologous vaccine challenge trial recently showed that a delayed dosing regimen with recombinant PvDBPII SalI variant formulated with adjuvant Matrix-MTM reduced the in vivo parasite multiplication rate (PMR) in immunized volunteers challenged with the Thai P. vivax isolate PvW1. Here, we describe extensive analysis of the polyfunctional antibody responses elicited by PvDBPII immunization and identify immune correlates for PMR reduction...
January 6, 2024: NPJ Vaccines
keyword
keyword
37876
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.